FOXO3 and cancer: This miR leads to the downregulation of FOXO3a (the Forkhead transcription factor O subfamily), which normally acts as a tumour suppressor gene, increases OSCC chemoresistance for DDP, and is directly associated with aggressive progression and poor prognosis in cancers [101,102].